181 related articles for article (PubMed ID: 33563649)
21. TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?
Gupta M; Babic A; Beck AH; Terry K
Hum Pathol; 2016 Aug; 54():82-91. PubMed ID: 27068525
[TBL] [Abstract][Full Text] [Related]
22. Circulating Inflammation Markers and Pancreatic Cancer Risk: A Prospective Case-Cohort Study in Japan.
Ma E; Shimazu T; Song M; Charvat H; Sawada N; Yamaji T; Inoue M; Camargo MC; Kemp TJ; Pfeiffer RM; Pinto LA; Rabkin CS; Tsugane S
Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):236-241. PubMed ID: 34697062
[TBL] [Abstract][Full Text] [Related]
23. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
[TBL] [Abstract][Full Text] [Related]
24. Circulating prolactin levels and risk of epithelial ovarian cancer.
Clendenen TV; Arslan AA; Lokshin AE; Liu M; Lundin E; Koenig KL; Berrino F; Hallmans G; Idahl A; Krogh V; Lukanova A; Marrangoni A; Muti P; Nolen BM; Ohlson N; Shore RE; Sieri S; Zeleniuch-Jacquotte A
Cancer Causes Control; 2013 Apr; 24(4):741-8. PubMed ID: 23378139
[TBL] [Abstract][Full Text] [Related]
25. Prediagnostic Serum Levels of Fatty Acid Metabolites and Risk of Ovarian Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Hada M; Edin ML; Hartge P; Lih FB; Wentzensen N; Zeldin DC; Trabert B
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):189-197. PubMed ID: 30262599
[TBL] [Abstract][Full Text] [Related]
26. The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients.
Kim SJ; Ryu KJ; Hong M; Ko YH; Kim WS
J Hematol Oncol; 2015 May; 8():49. PubMed ID: 25966773
[TBL] [Abstract][Full Text] [Related]
27. Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Lang Kuhs KA; Hildesheim A; Trabert B; Kemp TJ; Purdue MP; Wentzensen N; Katki HA; Pinto LA; Loftfield E; Safaeian M; Chaturvedi AK; Shiels MS
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):825-32. PubMed ID: 25713025
[TBL] [Abstract][Full Text] [Related]
28. Acrylamide hemoglobin adduct levels and ovarian cancer risk: a nested case-control study.
Xie J; Terry KL; Poole EM; Wilson KM; Rosner BA; Willett WC; Vesper HW; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):653-60. PubMed ID: 23417989
[TBL] [Abstract][Full Text] [Related]
29. Fully sialylated alpha-chain of complement 4-binding protein (A2160): a novel prognostic marker for epithelial ovarian carcinoma.
Matsuo K; Tanabe K; Ikeda M; Shibata T; Kajiwara H; Miyazawa M; Miyazawa M; Hayashi M; Shida M; Hirasawa T; Roman LD; Mikami M
Arch Gynecol Obstet; 2018 Mar; 297(3):749-756. PubMed ID: 29340789
[TBL] [Abstract][Full Text] [Related]
30. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort.
Grote VA; Kaaks R; Nieters A; Tjønneland A; Halkjær J; Overvad K; Skjelbo Nielsen MR; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Teucher B; Becker S; Pischon T; Boeing H; Trichopoulou A; Cassapa C; Stratigakou V; Palli D; Krogh V; Tumino R; Vineis P; Panico S; Rodríguez L; Duell EJ; Sánchez MJ; Dorronsoro M; Navarro C; Gurrea AB; Siersema PD; Peeters PH; Ye W; Sund M; Lindkvist B; Johansen D; Khaw KT; Wareham N; Allen NE; Travis RC; Fedirko V; Jenab M; Michaud DS; Chuang SC; Romaguera D; Bueno-de-Mesquita HB; Rohrmann S
Br J Cancer; 2012 May; 106(11):1866-74. PubMed ID: 22617158
[TBL] [Abstract][Full Text] [Related]
31. Assessment of chemokine serum levels in epithelial ovarian cancer patients.
Falcão-Júnior JO; Teixeira-Carvalho A; Cândido EB; Lages EL; Ferreira Freitas G G; Lamaita RM; Freire Bonfim LP; Borges Salera R; Traiman P P; da Silva-Filho AL
Tumori; 2013; 99(4):540-4. PubMed ID: 24326845
[TBL] [Abstract][Full Text] [Related]
32. Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission.
Wang S; Yang T; Wan J; Zhang Y; Fan Y
Brain Behav; 2017 Apr; 7(4):e00648. PubMed ID: 28413701
[TBL] [Abstract][Full Text] [Related]
33. Lifetime ovulatory years and ovarian cancer gene expression profiles.
Sasamoto N; Stewart PA; Wang T; Yoder SJ; Chellappan S; Hecht JL; Fridley BL; Terry KL; Tworoger SS
J Ovarian Res; 2022 May; 15(1):59. PubMed ID: 35562768
[TBL] [Abstract][Full Text] [Related]
34. [Clinical validation of multiple biomarkers suspension array technology for ovarian cancer].
Zhao BB; Yang ZJ; Wang Q; Pan ZM; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):11-19. PubMed ID: 28190310
[No Abstract] [Full Text] [Related]
35. Plasma androgen concentrations and risk of incident ovarian cancer.
Tworoger SS; Lee IM; Buring JE; Hankinson SE
Am J Epidemiol; 2008 Jan; 167(2):211-8. PubMed ID: 17982156
[TBL] [Abstract][Full Text] [Related]
36. Circulating soluble Fas levels and risk of ovarian cancer.
Akhmedkhanov A; Lundin E; Guller S; Lukanova A; Micheli A; Ma Y; Afanasyeva Y; Zeleniuch-Jacquotte A; Krogh V; Lenner P; Muti P; Rinaldi S; Kaaks R; Berrino F; Hallmans G; Toniolo P
BMC Cancer; 2003 Dec; 3():33. PubMed ID: 14690548
[TBL] [Abstract][Full Text] [Related]
37. Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.
Conroy SM; Maskarinec G; Morimoto Y; Franke AA; Cooney RV; Wilkens LR; Goodman MT; Hernadez BY; Le Marchand L; Henderson BE; Kolonel LN
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):337-47. PubMed ID: 23300021
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
[TBL] [Abstract][Full Text] [Related]
39. Anthropometric measures and risk of epithelial ovarian cancer: results from the nurses' health study.
Kotsopoulos J; Baer HJ; Tworoger SS
Obesity (Silver Spring); 2010 Aug; 18(8):1625-31. PubMed ID: 20035276
[TBL] [Abstract][Full Text] [Related]
40. Prediagnosis Leukocyte Telomere Length and Risk of Ovarian Cancer.
Yang M; Prescott J; Poole EM; Rice MS; Kubzansky LD; Idahl A; Lundin E; De Vivo I; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):339-345. PubMed ID: 28209595
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
